Skip to main content

Trade-Ideas LLC identified

LDR

(

LDRH

) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified LDR as such a stock due to the following factors:

  • LDRH has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $9.8 million.
  • LDRH traded 144,292 shares today in the pre-market hours as of 9:09 AM, representing 41% of its average daily volume.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in LDRH with the Ticky from Trade-Ideas. See the FREE profile for LDRH NOW at Trade-Ideas

More details on LDRH:

LDR Holding Corporation, a medical device company, focuses on designing and commercializing various surgical technologies for the treatment of patients suffering from spine disorders in the United States and internationally. Currently there are 7 analysts that rate LDR a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for LDR has been 281,100 shares per day over the past 30 days. LDR has a market cap of $965.1 million and is part of the health care sector and health services industry. Shares are up 12.8% year-to-date as of the close of trading on Wednesday.

TheStreet Recommends

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates LDR as a

sell

. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow and feeble growth in its earnings per share.

Highlights from the ratings report include:

  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income has significantly decreased by 150.2% when compared to the same quarter one year ago, falling from -$2.33 million to -$5.83 million.
  • Net operating cash flow has significantly decreased to -$2.17 million or 480.87% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • LDR HOLDING CORP has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. We feel it is likely to report a decline in earnings in the coming year. During the past fiscal year, LDR HOLDING CORP continued to lose money by earning -$0.44 versus -$0.98 in the prior year. For the next year, the market is expecting a contraction of 58.0% in earnings (-$0.70 versus -$0.44).
  • The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, LDR HOLDING CORP's return on equity significantly trails that of both the industry average and the S&P 500.
  • Looking at where the stock is today compared to one year ago, we find that it is higher, and it has outperformed the rise in the S&P 500 over the same period, despite the company's weak earnings results. Turning our attention to the future direction of the stock, we do not believe this stock offers ample reward opportunity to compensate for the risks, despite the fact that it rose over the past year.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.